Explore the gap between regulatory science and medical education regarding generic drug equivalence. Learn why doctors hesitate to prescribe generics and how new training methods can bridge the knowledge-behavior divide.
Jul 9 2026
Explore the FDA's strict bioequivalence standards for NTI drugs, including the 90-111% range and why these medications require specialized regulatory hurdles.
Apr 23 2026
Discover how the placebo and nocebo effects influence your experience with generic vs brand-name drugs and learn how to manage the psychological switch.
Apr 10 2026
Combination NTI drugs offer powerful treatment for complex conditions, but generic versions are nearly nonexistent due to strict bioequivalence challenges. Patients face higher risks, costs, and gaps in care.
Jan 31 2026
© 2026. All rights reserved.
Menu